GLUCOSIDASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF PULMONARY INFECTIONS
The present invention relates generally to glucosidase inhibitors and their use in treating or preventing pulmonary diseases. In particular, the present invention is directed to use of α-glucosidase inhibitors for treating or preventing bacterial or viral infections of the respiratory tract, includi...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MORTON, David Alexander Vodden TUCKER, Simon Peter MARCUCCIO, Sebastian Mario |
| description | The present invention relates generally to glucosidase inhibitors and their use in treating or preventing pulmonary diseases. In particular, the present invention is directed to use of α-glucosidase inhibitors for treating or preventing bacterial or viral infections of the respiratory tract, including SARS-CoV-2.
La présente invention concerne de manière générale des inhibiteurs de glucosidase et leur utilisation dans le traitement ou la prévention de maladies pulmonaires. En particulier, la présente invention concerne l'utilisation d'inhibiteurs d'alpha-glucosidase pour traiter ou prévenir des infections bactériennes ou virales du tractus respiratoire, y compris le SARS-CoV-2. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022040741A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022040741A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022040741A13</originalsourceid><addsrcrecordid>eNrjZPB39wl19g_2dHEMdlXw9PPwdPIM8Q8KVnDzD1II8XBVCAlydQzxdfULUXD0c1EICHINA7I9_f0U_N0UAkJ9fP39HIMigRrdXJ1BwsE8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSQ-3N_IwMjIwMTA3MTQ0dCYOFUAMGkwBw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GLUCOSIDASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF PULMONARY INFECTIONS</title><source>esp@cenet</source><creator>MORTON, David Alexander Vodden ; TUCKER, Simon Peter ; MARCUCCIO, Sebastian Mario</creator><creatorcontrib>MORTON, David Alexander Vodden ; TUCKER, Simon Peter ; MARCUCCIO, Sebastian Mario</creatorcontrib><description>The present invention relates generally to glucosidase inhibitors and their use in treating or preventing pulmonary diseases. In particular, the present invention is directed to use of α-glucosidase inhibitors for treating or preventing bacterial or viral infections of the respiratory tract, including SARS-CoV-2.
La présente invention concerne de manière générale des inhibiteurs de glucosidase et leur utilisation dans le traitement ou la prévention de maladies pulmonaires. En particulier, la présente invention concerne l'utilisation d'inhibiteurs d'alpha-glucosidase pour traiter ou prévenir des infections bactériennes ou virales du tractus respiratoire, y compris le SARS-CoV-2.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220303&DB=EPODOC&CC=WO&NR=2022040741A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220303&DB=EPODOC&CC=WO&NR=2022040741A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MORTON, David Alexander Vodden</creatorcontrib><creatorcontrib>TUCKER, Simon Peter</creatorcontrib><creatorcontrib>MARCUCCIO, Sebastian Mario</creatorcontrib><title>GLUCOSIDASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF PULMONARY INFECTIONS</title><description>The present invention relates generally to glucosidase inhibitors and their use in treating or preventing pulmonary diseases. In particular, the present invention is directed to use of α-glucosidase inhibitors for treating or preventing bacterial or viral infections of the respiratory tract, including SARS-CoV-2.
La présente invention concerne de manière générale des inhibiteurs de glucosidase et leur utilisation dans le traitement ou la prévention de maladies pulmonaires. En particulier, la présente invention concerne l'utilisation d'inhibiteurs d'alpha-glucosidase pour traiter ou prévenir des infections bactériennes ou virales du tractus respiratoire, y compris le SARS-CoV-2.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPB39wl19g_2dHEMdlXw9PPwdPIM8Q8KVnDzD1II8XBVCAlydQzxdfULUXD0c1EICHINA7I9_f0U_N0UAkJ9fP39HIMigRrdXJ1BwsE8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSQ-3N_IwMjIwMTA3MTQ0dCYOFUAMGkwBw</recordid><startdate>20220303</startdate><enddate>20220303</enddate><creator>MORTON, David Alexander Vodden</creator><creator>TUCKER, Simon Peter</creator><creator>MARCUCCIO, Sebastian Mario</creator><scope>EVB</scope></search><sort><creationdate>20220303</creationdate><title>GLUCOSIDASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF PULMONARY INFECTIONS</title><author>MORTON, David Alexander Vodden ; TUCKER, Simon Peter ; MARCUCCIO, Sebastian Mario</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022040741A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MORTON, David Alexander Vodden</creatorcontrib><creatorcontrib>TUCKER, Simon Peter</creatorcontrib><creatorcontrib>MARCUCCIO, Sebastian Mario</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MORTON, David Alexander Vodden</au><au>TUCKER, Simon Peter</au><au>MARCUCCIO, Sebastian Mario</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GLUCOSIDASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF PULMONARY INFECTIONS</title><date>2022-03-03</date><risdate>2022</risdate><abstract>The present invention relates generally to glucosidase inhibitors and their use in treating or preventing pulmonary diseases. In particular, the present invention is directed to use of α-glucosidase inhibitors for treating or preventing bacterial or viral infections of the respiratory tract, including SARS-CoV-2.
La présente invention concerne de manière générale des inhibiteurs de glucosidase et leur utilisation dans le traitement ou la prévention de maladies pulmonaires. En particulier, la présente invention concerne l'utilisation d'inhibiteurs d'alpha-glucosidase pour traiter ou prévenir des infections bactériennes ou virales du tractus respiratoire, y compris le SARS-CoV-2.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2022040741A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | GLUCOSIDASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF PULMONARY INFECTIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A31%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MORTON,%20David%20Alexander%20Vodden&rft.date=2022-03-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022040741A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |